Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with …
H Kameda, H Nagasawa, H Ogawa… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: Acute/subacute interstitial pneumonia (A/SIP) in patients with polymyositis/dermatomyositis
(PM/DM) is frequently fatal within months despite high dose prednisolone (PSL) …
(PM/DM) is frequently fatal within months despite high dose prednisolone (PSL) …
Incidence of cytomegalovirus reactivation in patients with inflammatory connective tissue diseases who are under immunosuppressive therapy.
T Mori, H Kameda, H Ogawa, A Iizuka… - The Journal of …, 2004 - jrheum.org
Incidence of Cytomegalovirus Reactivation in Patients with Inflammatory Connective Tissue
Diseases Who Are Under Immunosuppressi Page 1 Personal non-commercial use only. The …
Diseases Who Are Under Immunosuppressi Page 1 Personal non-commercial use only. The …
A case of multiple giant coronary aneurysms and abdominal aortic aneurysm coexisting with IgG4-related disease
…, A Okuyama, E Nishi, Y Shirai, T Kondo, H Ogawa… - Internal …, 2012 - jstage.jst.go.jp
IgG4-related disease (IgG4RD) is a unique systemic lymphoproliferative disorder characterized
by elevated serum IgG4 levels and IgG4-producing plasma cell expansion in the affected …
by elevated serum IgG4 levels and IgG4-producing plasma cell expansion in the affected …
Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis
H Ogawa, H Kameda, H Nagasawa… - Modern …, 2007 - academic.oup.com
We evaluated the efficacy and safety of low-dose cyclosporine A (CsA) in patients with
refractory lupus nephritis. Nine patients with systemic lupus erythematosus who had lupus …
refractory lupus nephritis. Nine patients with systemic lupus erythematosus who had lupus …
Single center prospective study of tacrolimus efficacy and safety in treatment of rheumatoid arthritis
…, H Takei, N Sekiguchi, E Nishi, H Ogawa… - Rheumatology …, 2009 - Springer
The aim of this study was to prospectively evaluate the efficacy and safety of tacrolimus for
treating rheumatoid arthritis (RA) patients in clinical practice. Fifty-five active RA patients who …
treating rheumatoid arthritis (RA) patients in clinical practice. Fifty-five active RA patients who …
Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis
E Nishi, H Kameda, H Ogawa, H Nagasawa… - Modern …, 2013 - academic.oup.com
Objective: We investigated the efficacy of a high-dose intermittent dosing treatment method (weekly
mizoribine pulse therapy) conceived in the hope of achieving better efficacy by …
mizoribine pulse therapy) conceived in the hope of achieving better efficacy by …
Development and validation of handy rheumatoid activity score with 38 joints (HRAS38) in rheumatoid arthritis patients receiving infliximab
…, H Takei, K Suzuki, E Nishi, H Ogawa… - Modern …, 2006 - academic.oup.com
The parameters involved in the Disease Activity Score of 28 joints (DAS28) are not mutually
independent, and the evaluation excludes ankle and foot joints. We developed a new …
independent, and the evaluation excludes ankle and foot joints. We developed a new …
Notable difference between the development of vertebral fracture and osteonecrosis of the femoral head in patients treated with high-dose glucocorticoids for systemic …
H Kameda, K Amano, H Nagasawa, H Ogawa… - Internal …, 2009 - jstage.jst.go.jp
Objective Vertebral fracture (VF) and osteonecrosis of the femoral head (OFH) are serious
concerns in patients with rheumatic diseases treated with high-dose glucocorticoids (GCs). …
concerns in patients with rheumatic diseases treated with high-dose glucocorticoids (GCs). …
Factors predicting the response to low-dose methotrexate therapy in patients with rheumatoid arthritis: a better response in male patients
…, K Amano, N Sekiguchi, H Takei, H Ogawa… - Modern …, 2004 - Springer
Methotrexate (MTX) is the most commonly used disease-modifying antirheumatic drug (DMARD)
throughout the world. In Japan, MTX is recommended by the Japanese Ministry of …
throughout the world. In Japan, MTX is recommended by the Japanese Ministry of …
Successful treatment of class IV+ V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide
…, R Sakai, A Shibata, K Chino, H Ogawa… - Internal …, 2013 - jstage.jst.go.jp
A substantial number of patients with lupus nephritis (LN) are refractory to conventional
glucocorticoid (GC) treatment. Although many of these patients respond to immunosuppressive …
glucocorticoid (GC) treatment. Although many of these patients respond to immunosuppressive …